<HTML><HEAD></HEAD><BODY>Swedish Orphan Biovitrum to expand Cyanokit distribution | TradingMarkets.com  New ETF Book by Larry Connors Click here to read more
</br>
 Swedish Orphan Biovitrum to expand Cyanokit distribution
</br>
Posted on: Thu, 01 Apr 2010 11:46:13 EDT
</br>
,  Do you know when to trade  &  ?Check for a  from TradingMarkets  Apr 01, 2010 NORDIC BUSINESS REPORT via COMTEX 1 April 2010 Biotech company Swedish Orphan Biovitrum STO: BVT said today it agreed with Merck Serono, a unit of German pharma company Merck KGaA ETR:  , to expand the distribution of the antidote Cyanokit to Ireland, the UK and the Netherlands.The financial details on the deal were not disclosed.The Swedish company currently distributes Cyanokit, or hydroxocobalamin, in the Nordic and the Baltic countries.Cyanokit is indicated for the treatment of known or suspected cyanide poisoning is administered intravenously.Comments on this story may be sent to nbr.feedback@nordicbusinessreport.com For full details on Merck & Co MRK .Merck & Co MRK has Short Term PowerRatings at TradingMarkets.Details on Merck & Co MRK Short Term PowerRatings is available at For full details on MKGAY .MKGAY has Short Term PowerRatings at TradingMarkets.Details on MKGAY Short Term PowerRatings is available at Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day.Join us for our  20 minute tele seminars during the week.Thursday April 29 12:30 PM Hear What Kevin Haggerty Sees in the Stock Market Today!Wednesday April 28 01:00 PM Hear What Gary Kaltbaum Sees in the Stock Market Today!* Attendance is strictly limited and are filled on a first come, first served basis. </br>
</BODY></HTML>